|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 209/48 | (2006.01) |
| G01N2800/52 | (2013.01) | ||
| A61K 31/404 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 45/06 | (2006.01) | ||
| G01N 33/57407 | (2013.01) | ||
| C07D 471/04 | (2006.01) | ||
| A61K 31/454 | (2013.01) | ||
| C07D 473/34 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/704 | (2013.01) | ||
| G01N2333/70539 | (2013.01) | ||
| A61K 31/4035 | (2013.01) |
| (11) | Number of the document | 3313818 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16815375.7 |
| Date of filing the European patent application | 2016-06-24 | |
| (97) | Date of publication of the European application | 2018-05-02 |
| (45) | Date of publication and mention of the grant of the patent | 2023-11-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/039245 |
| Date | 2016-06-24 |
| (87) | Number | WO 2016/210262 |
| Date | 2016-12-29 |
| (30) | Number | Date | Country code |
| 201562185265 P | 2015-06-26 | US |
| (72) |
YARCHOAN, Robert , US
ZELDIS, Jerome , US
POLIZZOTTO, Mark , AU
DAVIS, David , US
SERETI, Irini , US
ULDRICK, Thomas , US
WHITBY, Denise , US
KHETANI, Vikram , US
|
| (73) |
Celgene Corporation ,
Route 206 & Province Line Road, Princeton, NJ 08543,
US
The U.S.A. as represented by the Secretary, Department of Health and Human Services , Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard, Suite 325 MSC 7660, Bethesda, MD 20892-7660, US |
| (54) | METHODS FOR THE TREATMENT OF KAPOSI'S SARCOMA OR KSHV-INDUCED LYMPHOMA USING IMMUNOMODULATORY COMPOUNDS, AND USES OF BIOMARKERS |
| METHODS FOR THE TREATMENT OF KAPOSI'S SARCOMA OR KSHV-INDUCED LYMPHOMA USING IMMUNOMODULATORY COMPOUNDS, AND USES OF BIOMARKERS |